Lung Cancer Monthly Minutes

Shifts in Lung Cancer Treatment

Shifts in Lung Cancer Treatment

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon reviews how certain drugs can change the landscape for treating patients with lung cancer. Read More ›

A Look at PD-1 and PD-L1 Inhibitors

A Look at PD-1 and PD-L1 Inhibitors

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon discusses the use of PD-1 and PD-L1 inhibitors in patients with lung cancer. Read More ›

ALK Gene Rearrangement and PD-L1 Expression

ALK Gene Rearrangement and PD-L1 Expression

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon does not believe there is much value in utilizing PD-L1 inhibitors for pateints with ALK gene rearrangement. Read More ›

Differences in NSCLC Patient Populations

Differences in NSCLC Patient Populations

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data. Read More ›

Choosing the Right Therapy for Patients with NSCLC

Choosing the Right Therapy for Patients with NSCLC

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice. Read More ›

Immunotherapies and Lung Cancer

Immunotherapies and Lung Cancer

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon explains how he discusses immunotherapies with patients. Read More ›

My Practice: Roles and Responsibilities

My Practice: Roles and Responsibilities

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon describes how staff at his practice interacts with patients. Read More ›

Challenges in Managing Toxicities

Challenges in Managing Toxicities

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon believes it's important to recognize that agents without efficacy are not beneficial to the patient despite low toxicity. Read More ›

E-Cigarettes: The New Threat to Public Health

By Meg Barbor, MPH

TON - March 2017, Vol 10, No 2

It is now widely known that light cigarettes are no safer than regular cigarettes and were only marketed in an attempt to undermine smokers’ wishes to quit smoking. According to Charlotta Pisinger, PhD, MPH, the tobacco industry is now using the same tactic with electronic cigarettes (e-cigarettes). Read More ›

Managing Immune-Related Toxicities in Patients with Lung Cancer

By Meg Barbor, MPH

TON - March 2017, Vol 10, No 2

Toxicities related to immunotherapies approved for the treatment of patients with non–small-cell lung cancer (NSCLC) are uncommon but can be life-threatening. Read More ›

Page 22 of 25

19
20
21
22
23
24
25

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.

Subscribe to receive the free, TON print publication, and TON Bi-Weekly e‑newsletter.

Subscribe